Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-10-17 02:41 | 2018-10-13 | REIS | N/A | MOODYS CORP /DE/ | 10% owner | Other | BUY | $23.00 | 11,570,797 | $266,128,331 | 14,128,253 | +452.4% |
| 2018-10-12 23:10 | 2018-10-10 | CTACU | GRID DYNAMICS HOLDINGS, INC. | Chaserg Technology Sponsor LLC | 10% owner | Services-Prepackaged Software | BUY | $10.00 | 500,000 | $5,000,000 | 500,000 | +100.0% |
| 2018-10-13 01:00 | 2018-10-10 | GCP | N/A | Dalbergia Investments LLC | 10% owner | Other | BUY | $25.04 | 720,675 | $18,046,927 | 5,383,881 | +15.5% |
| 2018-10-12 23:05 | 2018-10-10 | NES | N/A | Gates Capital Management, L.P. | 10% owner | Other | BUY | $9.92 | 377,800 | $3,747,587 | 5,401,079 | +7.5% |
| 2018-10-12 01:11 | 2018-10-09 | APPN | Appian Corporation | Abdiel Capital Management, LLC | 10% owner | Services-Prepackaged Software | BUY | $25.67 | 166,910 | $4,285,214 | 6,521,402 | +2.6% |
| 2018-10-11 23:01 | 2018-10-10 | TA | N/A | PORTNOY ADAM D. | Director | Other | BUY | $5.62 | 1,492,691 | $8,381,460 | 1,492,691 | +100.0% |
| 2018-10-12 00:20 | 2018-10-09 | RUN | Sunrun Inc. | TIGER GLOBAL MANAGEMENT LLC | 10% owner | Miscellaneous Electrical Machinery, Equipment & Supplies | BUY | $11.47 | 231,357 | $2,653,942 | 15,231,357 | +1.5% |
| 2018-10-12 00:57 | 2018-10-09 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $10.00 | 2,500,000 | $25,000,000 | 8,374,935 | +42.6% |
| 2018-10-10 20:42 | 2018-10-10 | OCCI | OFS Credit Company, Inc. | Cerny Jeffrey A | Director, Officer - Director and CFO | Other | BUY | $20.00 | 77,500 | $1,550,000 | 70,000 | +100.0% |
| 2018-10-10 20:39 | 2018-10-10 | OCCI | OFS Credit Company, Inc. | Orchard First Source Asset Management, LLC | Other | Other | BUY | $20.00 | 70,000 | $1,400,000 | 70,000 | +100.0% |
| 2018-10-10 20:41 | 2018-10-10 | OCCI | OFS Credit Company, Inc. | Rashid Bilal | Director, Officer - President, Director and CEO | Other | BUY | $20.00 | 77,500 | $1,550,000 | 70,000 | +100.0% |
| 2018-10-09 23:46 | 2018-10-05 | KALA | KALA BIO, Inc. | Grunberg Gregory | Director | Pharmaceutical Preparations | BUY | $8.25 | 606,060 | $4,999,995 | 2,877,006 | +26.7% |
| 2018-10-09 23:43 | 2018-10-04 | N/A | Blue Owl Capital Corp | Ostrover Douglas I | Director | Other | BUY | $15.30 | 179,189 | $2,741,592 | 878,112 | +25.6% |
| 2018-10-10 01:44 | 2018-10-05 | GCP | N/A | Dalbergia Investments LLC | 10% owner | Other | BUY | $25.79 | 477,374 | $12,311,619 | 4,663,206 | +11.4% |
| 2018-10-09 22:09 | 2018-10-05 | N-A | N/A | Golub Lawrence E | Director, Officer, 10% owner - Chairman | Other | BUY | $15.00 | 109,760 | $1,646,396 | 1,821,627 | +6.4% |
| 2018-10-09 22:11 | 2018-10-05 | N-A | N/A | Golub David | Director, Officer, 10% owner - President and CEO | Other | BUY | $15.00 | 109,760 | $1,646,396 | 1,821,627 | +6.4% |
| 2018-10-09 23:01 | 2018-10-05 | KMPH | ZEVRA THERAPEUTICS, INC. | Delaware Street Capital Master Fund, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $3.00 | 2,000,000 | $6,000,000 | 4,095,914 | +95.4% |
| 2018-10-09 23:20 | 2018-10-04 | MEET | N/A | Luxor Capital Group, LP | 10% owner | Other | BUY | $5.27 | 247,567 | $1,305,545 | 2,819,233 | +9.6% |
| 2018-10-10 00:19 | 2018-10-09 | SYNT | N/A | Atos S.E. | 10% owner | Other | BUY | $41.00 | 83,804,409 | $3,435,980,769 | 100 | +100.0% |
| 2018-10-05 18:10 | 2018-10-04 | N-A | N/A | STRS OHIO | 10% owner | Other | BUY | $15.00 | 133,333 | $2,000,000 | 1,864,702 | +7.7% |
| 2018-10-05 23:34 | 2018-10-03 | KALA | KALA BIO, Inc. | Shah Rajeev M. | Director, 10% owner | Pharmaceutical Preparations | BUY | $8.25 | 2,424,242 | $19,999,997 | 4,537,478 | +114.7% |
| 2018-10-06 01:58 | 2018-10-03 | APPN | Appian Corporation | Abdiel Capital Management, LLC | 10% owner | Services-Prepackaged Software | BUY | $28.39 | 375,824 | $10,671,109 | 6,354,492 | +6.3% |
| 2018-10-05 23:33 | 2018-10-03 | KALA | KALA BIO, Inc. | RA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $8.25 | 2,424,242 | $19,999,997 | 4,537,478 | +114.7% |
| 2018-10-06 00:10 | 2018-10-04 | IIPR | INNOVATIVE INDUSTRIAL PROPERTIES INC | Gold Alan D | Director, Officer - Executive Chairman | Real Estate | BUY | $40.00 | 67,500 | $2,700,000 | 33,750 | +100.0% |
| 2018-10-06 01:36 | 2018-10-05 | EPZM | N/A | MOTT DAVID M | Director | Other | BUY | $9.00 | 416,667 | $3,750,003 | 6,471,018 | +6.9% |
| 2018-10-05 01:02 | 2018-03-30 | MVEN | Arena Group Holdings Inc. | STROME MARK E | 10% owner | Cable & Other Pay Television Services | BUY | $2.34 | 600,505 | $1,405,422 | 4,485,268 | +15.5% |
| 2018-10-05 01:15 | 2018-10-02 | GCP | N/A | Dalbergia Investments LLC | 10% owner | Other | BUY | $26.26 | 101,900 | $2,675,894 | 4,185,832 | +2.5% |
| 2018-10-05 00:31 | 2018-10-02 | GTT | N/A | SPRUCE HOUSE PARTNERSHIP LP | 10% owner | Other | BUY | $44.11 | 387,933 | $17,110,057 | 10,000,000 | +4.0% |
| 2018-10-04 00:01 | 2018-10-01 | OCPIX | N/A | OppenheimerFunds, Inc. | 10% owner | Other | BUY | $10.07 | 496,524 | $5,000,000 | 4,242,277 | +13.3% |
| 2018-10-04 00:47 | 2018-10-01 | UROV | N/A | SVF Investments (UK) Ltd | 10% owner | Other | BUY | $14.00 | 2,678,571 | $37,499,994 | 22,703,669 | +13.4% |
| 2018-10-04 02:18 | 2018-10-01 | UROV | N/A | Lo Andrew | 10% owner | Other | BUY | $14.00 | 2,678,571 | $37,499,994 | 22,703,669 | +13.4% |
| 2018-10-04 00:18 | 2018-10-01 | ARVN | Arvinas Inc. | Loven Jakob | Director | Pharmaceutical Preparations | BUY | $16.00 | 312,500 | $5,000,000 | 312,500 | +100.0% |
| 2018-10-04 00:58 | 2018-10-01 | UROV | N/A | Dexxon Holdings Ltd. | 10% owner | Other | BUY | $14.00 | 2,678,571 | $37,499,994 | 22,703,669 | +13.4% |
| 2018-10-03 23:48 | 2018-10-01 | UROV | N/A | Roivant Sciences Ltd. | 10% owner | Other | BUY | $14.00 | 2,678,571 | $37,499,994 | 22,703,669 | +13.4% |
| 2018-10-04 00:22 | 2018-10-01 | ARVN | Arvinas Inc. | Ratcliffe Liam | Director | Pharmaceutical Preparations | BUY | $16.00 | 1,000,000 | $16,000,000 | 375,000 | +100.0% |
| 2018-10-03 20:52 | 2018-10-01 | OCPIX | N/A | TC Group Cayman Investment Holdings, L.P. | 10% owner | Other | BUY | $10.07 | 496,524 | $5,000,000 | 4,245,276 | +13.2% |
| 2018-10-03 23:36 | 2018-10-01 | ARVN | Arvinas Inc. | RA CAPITAL MANAGEMENT, LLC | Other | Pharmaceutical Preparations | BUY | $16.00 | 1,000,000 | $16,000,000 | 3,138,412 | +46.8% |
| 2018-10-03 23:49 | 2018-10-01 | UROV | N/A | Machado Patrick | 10% owner | Other | BUY | $14.00 | 2,678,571 | $37,499,994 | 22,703,669 | +13.4% |
| 2018-10-04 00:50 | 2018-10-01 | UROV | N/A | QVT Associates GP LLC | 10% owner | Other | BUY | $14.00 | 2,678,571 | $37,499,994 | 22,703,669 | +13.4% |
| 2018-10-04 00:56 | 2018-10-01 | UROV | N/A | VIKING GLOBAL INVESTORS LP | 10% owner | Other | BUY | $14.00 | 2,678,571 | $37,499,994 | 22,703,669 | +13.4% |
| 2018-10-04 00:52 | 2018-10-01 | UROV | N/A | VIKING GLOBAL PERFORMANCE LLC | 10% owner | Other | BUY | $14.00 | 2,678,571 | $37,499,994 | 22,703,669 | +13.4% |
| 2018-10-03 04:35 | 2018-09-28 | ETTX | N/A | ASTRAZENECA PLC | 10% owner | Other | BUY | $15.00 | 246,666 | $3,699,990 | 2,164,855 | +12.9% |
| 2018-10-03 04:39 | 2018-09-28 | ETTX | N/A | Pivotal bioVenture Partners Fund I, L.P. | 10% owner | Other | BUY | $15.00 | 337,724 | $5,065,860 | 1,180,178 | +40.1% |
| 2018-10-03 04:40 | 2018-09-28 | ETTX | N/A | Preston Heather | Director, 10% owner | Other | BUY | $15.00 | 337,724 | $5,065,860 | 1,180,178 | +40.1% |
| 2018-10-03 00:20 | 2018-09-28 | GRTS | N/A | Clarus Lifesciences III, L.P. | 10% owner | Other | BUY | $15.00 | 333,333 | $4,999,995 | 333,333 | +100.0% |
| 2018-10-02 23:08 | 2018-09-27 | SPKE | Via Renewables, Inc. | Maxwell W Keith III | Director, 10% owner | Electric & Other Services Combined | BUY | $8.20 | 123,904 | $1,015,492 | 1,184,338 | +11.7% |
| 2018-10-02 17:01 | 2018-09-28 | AIRT | Air T, Inc. | Swenson Nicholas John | Director, Officer, 10% owner - CEO | Air Courier Services | BUY | $33.55 | 30,000 | $1,006,500 | 32,304 | +1,302.1% |
| 2018-10-03 00:23 | 2018-09-28 | GRTS | N/A | Simon Nicholas | Director, 10% owner | Other | BUY | $15.00 | 333,333 | $4,999,995 | 333,333 | +100.0% |
| 2018-10-02 21:31 | 2018-10-01 | STRO | SUTRO BIOPHARMA, INC. | Merck & Co., Inc. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $15.00 | 666,666 | $9,999,990 | 2,723,509 | +32.4% |
| 2018-10-03 04:38 | 2018-09-28 | ETTX | N/A | Frazier Life Sciences VIII, L.P. | 10% owner | Other | BUY | $15.00 | 375,887 | $5,638,305 | 1,349,953 | +38.6% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.